Chinese, Indian Firms Get FDA Thumbs-Down | Chemical & Engineering News
Volume 93 Issue 38 | pp. 20-21 | Concentrates
Issue Date: September 28, 2015

Chinese, Indian Firms Get FDA Thumbs-Down

Department: Business
Keywords: cGMP, FDA, pigeons, APIs, China, India

FDA has banned from the U.S. 15 active pharmaceutical ingredients (APIs) made by Zhejiang Hisun Pharmaceutical, one of China’s leading API makers and a partner with Pfizer in a generic drugs joint venture. Hisun says FDA inspectors faulted the integrity of the company’s manufacturing data. Hisun adds that the 15 APIs represent only about 2% of its sales. Separately, FDA is prolonging an import ban on APIs made by India’s Pan Drugs. During an inspection a year ago agency officials observed severe manufacturing deficiencies, including large holes in walls that allowed pigeons to enter the plant.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment